557 related articles for article (PubMed ID: 17960131)
1. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of glial cell line-derived neurotrophic factor (GDNF) protects retinal ganglion cells in a pig model of acute retinal ischemia.
Kyhn MV; Klassen H; Johansson UE; Warfvinge K; Lavik E; Kiilgaard JF; Prause JU; Scherfig E; Young M; la Cour M
Exp Eye Res; 2009 Dec; 89(6):1012-20. PubMed ID: 19735654
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat.
Lau J; Dang M; Hockmann K; Ball AK
Exp Eye Res; 2006 Jan; 82(1):132-45. PubMed ID: 16045909
[TBL] [Abstract][Full Text] [Related]
4. Exogenous modulation of intrinsic optic nerve neuroprotective activity.
Grozdanic SD; Lazic T; Kuehn MH; Harper MM; Kardon RH; Kwon YH; Lavik EB; Sakaguchi DS
Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1105-16. PubMed ID: 20229104
[TBL] [Abstract][Full Text] [Related]
5. GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection.
Lindqvist N; Peinado-Ramónn P; Vidal-Sanz M; Hallböök F
Exp Neurol; 2004 Jun; 187(2):487-99. PubMed ID: 15144875
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres.
Ward MS; Khoobehi A; Lavik EB; Langer R; Young MJ
J Pharm Sci; 2007 Mar; 96(3):558-68. PubMed ID: 17177208
[TBL] [Abstract][Full Text] [Related]
7. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse.
Andrieu-Soler C; Aubert-Pouëssel A; Doat M; Picaud S; Halhal M; Simonutti M; Venier-Julienne MC; Benoit JP; Behar-Cohen F
Mol Vis; 2005 Nov; 11():1002-11. PubMed ID: 16319820
[TBL] [Abstract][Full Text] [Related]
8. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
Urcola JH; Hernández M; Vecino E
Exp Eye Res; 2006 Aug; 83(2):429-37. PubMed ID: 16682027
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
11. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
Thanos S; Naskar R
Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
[TBL] [Abstract][Full Text] [Related]
12. GDNF gene therapy attenuates retinal ischemic injuries in rats.
Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP
Mol Vis; 2004 Feb; 10():93-102. PubMed ID: 14961006
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.
Tsai JC; Wu L; Worgul B; Forbes M; Cao J
Curr Eye Res; 2005 Nov; 30(11):1025-31. PubMed ID: 16282136
[TBL] [Abstract][Full Text] [Related]
14. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage.
Chauhan BC; Pan J; Archibald ML; LeVatte TL; Kelly ME; Tremblay F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2969-76. PubMed ID: 12202517
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
16. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.
Martin KR; Quigley HA; Valenta D; Kielczewski J; Pease ME
Exp Eye Res; 2006 Aug; 83(2):255-62. PubMed ID: 16546168
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma.
Tezel G; Yang X; Cai J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3177-87. PubMed ID: 16123417
[TBL] [Abstract][Full Text] [Related]
18. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
Naskar R; Wissing M; Thanos S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
[TBL] [Abstract][Full Text] [Related]
19. The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection.
Kilic U; Kilic E; Dietz GP; Bähr M
Neurodegener Dis; 2004; 1(1):44-9. PubMed ID: 16908973
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys.
Hauk TG; Leibinger M; Müller A; Andreadaki A; Knippschild U; Fischer D
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):459-64. PubMed ID: 19661221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
